Lyra Therapeutics, Inc.LYRANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Year-over-Year Change
Price-to-earnings ratio
Latest
-7.19
↑ 98% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-288.06
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -7.19 | +96.5% |
| 2023 | -207.94 | -142.1% |
| 2022 | -85.88 | -32.0% |
| 2021 | -65.06 | +70.4% |
| 2020 | -220.14 | +52.7% |
| 2019 | -465.69 | +51.7% |
| 2018 | -964.55 | - |